Psychiatry for ALFs & Skilled Nursing Facilities

The short answer

Stedfast Living provides on-site and telepsychiatry coverage for assisted living, memory care and skilled nursing facilities in Florida and South Carolina. The team rounds on a set schedule, documents psychotropic rationale and gradual dose reduction plans to CMS F-tag standards, supports PASRR and care planning, communicates with families, and bills residents' Medicare or insurance directly with no cost to the facility.

The program exists because psychiatric care in long-term care is usually either absent or reactive: a resident becomes agitated, an as-needed antipsychotic is ordered by phone, and the medication is still there six months later when the surveyor asks why. We replace that with scheduled rounding, documented rationale for every psychotropic, gradual dose reduction planning that meets CMS expectations, and a clinician your nurses can reach.

Who it is for

Skilled nursing facilities subject to CMS Requirements of Participation, particularly the psychotropic medication and unnecessary drug provisions surveyed under F-758 and F-757, and the behavioral health services requirements under F-740 through F-745. Assisted living facilities and memory care units licensed by the Florida Agency for Health Care Administration or the South Carolina Department of Health and Environmental Control, including those with limited mental health licenses in Florida. Independent living and continuing care communities whose residents need psychiatric follow-up without leaving campus.

The program suits facilities of any size that lack a consistent psychiatric prescriber, that are managing residents with dementia-related behaviors, that have received survey citations or plan-of-correction requirements involving psychotropics, or that want to reduce antipsychotic use in line with the CMS National Partnership goals. It also suits facilities with a high share of residents on antidepressants, hypnotics or anxiolytics that have never been reviewed for continued need.

How it works

Onboarding starts with a review of your resident census, current psychotropic utilization, and any recent survey findings. We agree on a rounding schedule, typically every two to four weeks depending on census and acuity, and identify a facility contact, usually the DON or a unit manager, who prepares a list of residents to be seen. Consent for psychiatric evaluation is obtained from the resident or their legal representative per facility policy, and we document it.

On rounding days the clinician reviews the chart and medication administration record, speaks with nursing staff about the resident's behavior since the last visit, evaluates the resident, and documents a progress note the same day. Each note addresses diagnosis, target symptoms, the rationale for each psychotropic, response, side effects including AIMS screening for antipsychotics, and the plan, including whether a gradual dose reduction is being attempted, has been attempted and failed, or is clinically contraindicated with the reason stated. That structure maps to what surveyors look for under F-758 and makes the pharmacy consultant's monthly review straightforward.

Between rounds, nurses contact our team for new concerns. We handle most by telepsychiatry, with the resident and a nurse on the facility's tablet, and we respond to urgent behavioral changes the same day. New admissions with psychiatric diagnoses can be seen by video before the first on-site round. PASRR Level II residents are tracked so that specialized services and follow-up are documented. We participate in care plan meetings and interdisciplinary team reviews on request, and we provide staff education on non-pharmacological approaches to behavioral symptoms, documentation of behaviors, and when to call.

The national rate of antipsychotic use among long-stay nursing home residents fell from 23.9 percent in 2011 to about 14.5 percent by 2022 under the CMS National Partnership to Improve Dementia Care.

Source: Centers for Medicare & Medicaid Services, National Partnership quarterly data

Up to 90 percent of people with dementia experience at least one behavioral or psychological symptom over the course of the illness.

Source: Alzheimer's Association; Cerejeira et al., Frontiers in Neurology, 2012

An estimated 65 to 90 percent of nursing home residents have a mental or behavioral health condition, including dementia, depression, and serious mental illness.

Source: Grabowski et al., Health Affairs, 2010; HHS Office of Inspector General

CMS surveyors cited F-758 (unnecessary psychotropic medications and gradual dose reduction) in thousands of surveys annually, making it one of the most frequently cited pharmacy-related deficiencies.

Source: CMS Nursing Home Compare deficiency data; LTC Trend Tracker

What to expect

A written service agreement that defines rounding frequency, response times, documentation standards and the facility contact. Progress notes in your chart on the day of service. A monthly summary of residents seen, psychotropic changes, GDR attempts and outcomes, suitable for QAPI review. A clinician reachable by phone during business hours and a defined after-hours process. Family communication, with consent, after significant changes.

We do not take over the attending physician's role. Orders for psychiatric medications are written by our clinicians within the facility's order process, and we coordinate with the attending and the consultant pharmacist on interactions and on medications prescribed by others. For residents whose psychiatric needs exceed what can be safely managed in the facility, we help arrange inpatient evaluation and support the return. In Florida, we are familiar with Baker Act procedures; in South Carolina, with the emergency admission process under state law.

Benefits

Scheduled on-site rounding with same-day documentation
Psychotropic rationale and GDR plans documented to CMS F-758 standards
Telepsychiatry coverage between rounds and for new admissions
Support for PASRR tracking, care planning and QAPI reporting
AIMS screening and side effect monitoring for residents on antipsychotics
Staff education on non-drug approaches to dementia-related behaviors
Family communication handled by the clinician, not left to nursing
Billed to resident coverage; no facility fee

Risks and side effects

The clinical risks in this population are well known: antipsychotics carry an FDA boxed warning for increased mortality in elderly patients with dementia-related psychosis, along with stroke, falls, sedation and movement disorder risk; benzodiazepines and hypnotics increase falls, confusion and delirium; antidepressants can cause hyponatremia and bleeding risk in combination with anticoagulants. Our prescribing follows the principle of lowest effective dose for the shortest necessary duration, with documented target symptoms and regular reassessment.

The program risk for a facility is a mismatch of expectations. We reduce psychotropic use where it is safe to do so, and that sometimes means behaviors that were suppressed by sedation re-emerge and need behavioral management by staff. We prepare facilities for that and provide the education to support it. We also will not write orders for medications that are not clinically indicated because a family or staff member requests them, and we document declined requests. Facilities that want a prescriber who will sedate on request should look elsewhere.

Cost and insurance

There is no cost to the facility for the Stedfast Living program. Psychiatric evaluation and follow-up visits are billed to the resident's Medicare Part B, Medicare Advantage plan, Medicaid where our clinicians participate, or commercial insurance, in the same way as any outpatient specialist visit delivered in a facility. For skilled nursing residents in a Part A stay, psychiatric professional services remain separately billable under Part B and are not part of the facility's consolidated billing. Telepsychiatry visits are billed under the applicable telehealth provisions, which Medicare has made permanent for mental health services in facility settings.

Residents or families are responsible for the usual Part B deductible and 20 percent coinsurance unless a supplemental plan covers it. We verify coverage at onboarding for each resident and notify the facility of any resident for whom we cannot bill. Self-pay rates are available for residents without coverage. Staff education sessions and participation in care plan meetings are included in the service agreement.

The regulatory frame

For skilled nursing facilities, the relevant CMS Requirements of Participation are F-757 (unnecessary drugs), F-758 (psychotropic drugs and gradual dose reduction, including the limits on PRN psychotropic orders), F-740 through F-745 (behavioral health services and the requirement that facilities provide treatment for residents with mental disorders and dementia), F-605 (chemical restraints) and F-756 (drug regimen review by the consultant pharmacist). PRN psychotropic orders are limited to 14 days unless the prescriber documents the rationale and duration for an extension, and PRN antipsychotic orders cannot be renewed without a direct evaluation. Our notes are written with those provisions in mind.

For Florida assisted living facilities, Chapter 429 of the Florida Statutes and Rule 59A-36 of the Florida Administrative Code govern resident care, and facilities with a limited mental health license carry additional obligations for residents with serious mental illness, including a community living support plan and a cooperative agreement with a mental health provider. Stedfast Living can serve as that provider. In South Carolina, community residential care facilities are regulated by DHEC under Regulation 61-84, and nursing homes under 61-17.

Gradual dose reduction in practice

CMS expects a GDR to be attempted for every resident on a psychotropic unless clinically contraindicated, and the contraindication must be specific: not "stable on current dose" but a documented history of decompensation on a prior taper, or a target symptom that recurred when the dose was lowered. For antipsychotics in residents who do not have a diagnosis that supports long-term use (schizophrenia, Huntington's disease, Tourette's syndrome), the expectation is two GDR attempts in the first year in separate quarters, then annually. Our approach is to plan the GDR at the time the medication is started, to taper slowly with defined behavioral monitoring by nursing, and to document the outcome either way. A failed GDR, properly documented, is compliant. An unattempted one is not.

Non-pharmacological approaches first

The majority of behavioral symptoms in dementia have an identifiable cause: pain, constipation, infection, hunger, fatigue, overstimulation, a change in staff or routine, or an attempt to communicate a need. Surveyors expect to see that these were assessed and that non-drug interventions were tried and documented before a psychotropic was added. We work with nursing on behavior logs that capture antecedents and timing, we review the medical causes at each visit, and we provide staff education on redirection, environmental modification and individualized approaches. This is not a formality. It is usually what works.

Documentation that holds up

A compliant psychiatric note in long-term care answers the surveyor's questions before they are asked. What is the diagnosis and does it support the medication? What specific, observable target symptoms is the medication treating? What non-drug approaches were tried? What is the response, and how is it measured? What side effects are being monitored, including AIMS and metabolic screening for antipsychotics? When was GDR last attempted, what happened, and when is the next attempt? Our notes follow that structure. They are legible, they are in the chart the same day, and they are consistent with the MAR and the pharmacist's review.

Telepsychiatry coverage

On-site rounding establishes the relationship and handles the evaluations that need a hands-on assessment. Telepsychiatry fills the gaps: a new admission with a psychiatric history who arrives on a Friday, a resident whose behavior changed overnight, a family who wants a conversation with the prescriber, a stable resident whose quarterly follow-up does not need a visit. Facilities need a tablet or laptop with a camera and a nurse who can be present. Medicare's permanent telehealth provisions for mental health services in facility settings cover these visits.

Family communication

Families of residents with dementia want two contradictory things: for their parent to be calm, and for their parent not to be sedated. Explaining why a particular medication was chosen, what it is for, what the alternatives are, and why a sedative that was requested is not appropriate takes time that nursing leadership does not have. Our clinicians take that conversation, with consent, and document it. It reduces complaints, it reduces pressure on staff to medicate, and it keeps families informed before the survey, not after.

Starting the program

Contact Stedfast Living for an introductory call. We ask for the census, the current psychotropic list, the most recent survey findings and the name of a clinical contact. From there a service agreement, a rounding schedule and a first visit usually follow within two to four weeks.

Frequently asked questions

How often does your team round?

Typically every two to four weeks, set by census and acuity in the service agreement. Memory care units and facilities with many residents on psychotropics are usually on a two-week cycle. Between rounds, telepsychiatry covers new concerns and new admissions, with same-day response for urgent behavioral changes during business hours.

How does this help with F-758 and GDR compliance?

Every progress note documents the diagnosis, target symptoms, rationale for each psychotropic, response, side effects including AIMS for antipsychotics, and the GDR status: attempted, planned, or clinically contraindicated with the specific reason. That is the documentation surveyors look for. We also attempt GDR on the CMS schedule, generally two attempts in the first year and annually thereafter unless contraindicated, and record outcomes.

Do you support PASRR requirements?

Yes. We identify residents with PASRR Level II determinations, ensure their specialized services and psychiatric follow-up are documented, and provide the clinical information needed for resident reviews when a significant change occurs. We do not perform the Level II evaluation itself, which is done by the state's contracted evaluator.

What does the facility pay?

Nothing. Visits are billed to each resident's Medicare Part B, Medicare Advantage, Medicaid where we participate, or commercial insurance, as separately billable professional services. Residents are responsible for the usual deductible and coinsurance unless a supplemental plan covers it. Staff education and care plan participation are included.

Can you see residents by telehealth?

Yes. Medicare has made telehealth for mental health services in facility settings permanent, and both Florida and South Carolina permit it. A nurse brings a tablet to the resident. We use telepsychiatry for new admissions before the first round, for urgent concerns between rounds, and for stable follow-ups where an in-person visit adds nothing. Initial evaluations and residents on antipsychotics are seen in person at regular intervals.

Do you communicate with families?

Yes, with the resident's or representative's consent. Our clinician calls the designated family contact after significant changes, explains medication decisions including why a sedative was not ordered, and joins care plan meetings on request. Taking that conversation off the DON's desk is one of the most valued parts of the program.

What about residents with serious mental illness rather than dementia?

We manage schizophrenia, bipolar disorder, major depression and other serious mental illness in facility residents, including long-acting injectable antipsychotics coordinated with the facility's nursing staff, clozapine monitoring, and mood stabilizer labs. Florida ALFs with limited mental health licenses have specific requirements for community living support plans, and we provide the psychiatric component.

How do we get started?

Contact Stedfast Living through our main number or the facility inquiry form. We schedule a call with the administrator and DON, review census and current psychotropic utilization, and draft a service agreement. Most facilities are onboarded and have their first rounding day within two to four weeks. Facilities under a plan of correction can be prioritized.

Where this treatment is offered

Conditions this treats

Behavioral and Psychological Symptoms of Dementia Depression in Older Adults Cognitive Decline, Dementia and Memory Concerns Schizophrenia and Psychotic Disorders Bipolar Disorder Major Depressive Disorder Generalized Anxiety Disorder Insomnia

If you are in crisis, call or text 988 or go to the nearest emergency room. Educational content; individual results vary. Reviewed by Dr. David Husted, board-certified psychiatrist.

Psychiatric Services for Assisted Living and Skilled Nursing Facilities